X-123184549-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000828.5(GRIA3):āc.14A>Cā(p.Lys5Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000414 in 1,206,609 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000090 ( 0 hom., 0 hem., cov: 21)
Exomes š: 0.0000036 ( 0 hom. 2 hem. )
Consequence
GRIA3
NM_000828.5 missense
NM_000828.5 missense
Scores
1
5
8
Clinical Significance
Conservation
PhyloP100: 2.33
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.19359592).
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIA3 | NM_000828.5 | c.14A>C | p.Lys5Thr | missense_variant | 1/16 | ENST00000622768.5 | NP_000819.4 | |
GRIA3 | NM_007325.5 | c.14A>C | p.Lys5Thr | missense_variant | 1/16 | ENST00000620443.2 | NP_015564.5 | |
GRIA3 | NM_001256743.2 | c.14A>C | p.Lys5Thr | missense_variant | 1/4 | NP_001243672.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRIA3 | ENST00000620443.2 | c.14A>C | p.Lys5Thr | missense_variant | 1/16 | 1 | NM_007325.5 | ENSP00000478489 | P4 | |
GRIA3 | ENST00000622768.5 | c.14A>C | p.Lys5Thr | missense_variant | 1/16 | 5 | NM_000828.5 | ENSP00000481554 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00000904 AC: 1AN: 110579Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32807
GnomAD3 genomes
AF:
AC:
1
AN:
110579
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32807
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000365 AC: 4AN: 1096030Hom.: 0 Cov.: 29 AF XY: 0.00000553 AC XY: 2AN XY: 361464
GnomAD4 exome
AF:
AC:
4
AN:
1096030
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
361464
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000904 AC: 1AN: 110579Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32807
GnomAD4 genome
AF:
AC:
1
AN:
110579
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32807
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1429226). This variant has not been reported in the literature in individuals affected with GRIA3-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.02%). This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 5 of the GRIA3 protein (p.Lys5Thr). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D;.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.;.;N;N
MutationTaster
Benign
N;N;N;N;N;N
PrimateAI
Uncertain
T
Sift4G
Pathogenic
D;T;D;T;T;T
Polyphen
0.016, 0.027
.;B;.;.;B;B
Vest4
MutPred
Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at